Efficacy of the Sentinox Spray in Reducing Viral Load in Mild COVID-19 and Its Virucidal Activity against Other Respiratory Viruses: Results of a Randomized Controlled Trial and an In Vitro Study
Donatella Panatto, Andrea Orsi, Bianca Bruzzone, Valentina Ricucci, Guido Fedele, Giorgio Reiner, Nadia Giarratana, Alexander Domnich, Giancarlo Icardi
Viruses, doi:10.3390/v14051033
Sentinox (STX) is an acid-oxidizing solution containing hypochlorous acid in spray whose virucidal activity against SARS-CoV-2 has been demonstrated. In this paper, results of a randomized controlled trial (RCT) on the efficacy of STX in reducing viral load in mild COVID-19 patients (NCT04909996) and a complementary in vitro study on its activity against different respiratory viruses are reported. In the RCT, 57 patients were randomized (1:1:1) to receive STX three (STX-3) or five (STX-5) times/day plus standard therapy or standard therapy only (controls). Compared with controls, the log 10 load reduction in groups STX-3 and STX-5 was 1.02 (p = 0.14) and 0.18 (p = 0.80), respectively. These results were likely driven by outliers with extreme baseline viral loads. When considering subjects with baseline cycle threshold values of 20-30, STX-3 showed a significant (p = 0.016) 2.01 log 10 reduction. The proportion of subjects that turned negative by the end of treatment (day 5) was significantly higher in the STX-3 group than in controls, suggesting a shorter virus clearance time. STX was safe and well-tolerated. In the in vitro study, ≥99.9% reduction in titers against common respiratory viruses was observed. STX is a safe device with large virucidal spectrum and may reduce viral loads in mild COVID-19 patients.
Supplementary Materials: The following supporting information can be downloaded at: https: //www.mdpi.com/article/10.3390/v14051033/s1 , Figure S1 : Overview of the study procedures;
References
Antimisiaris, Marazioti, Kannavou, Natsaridis, Gkartziou et al., Overcoming barriers by local drug delivery with liposomes, Adv. Drug. Deliv. Rev,
doi:10.1016/j.addr.2021.01.019
Burton, Clarkson, Goulao, Glenny, Mcbain et al., Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them, Cochrane Database Syst. Rev
Cho, Min, Chung, Park, Seong et al., Improved outcomes after lowconcentration hypochlorous acid nasal irrigation in pediatric chronic sinusitis, Laryngoscope,
doi:10.1002/lary.25605
Clonit, Quanty COVID-19v2
Contreras, Newby, Hillen, Personalized virus load curves for acute viral infections, Viruses,
doi:10.3390/v13091815
Dadashi, Khaleghnejad, Abedi Elkhichi, Goudarzi, Goudarzi et al., COVID-19 and influenza co-infection: A systematic review and meta-analysis, Front. Med,
doi:10.3389/fmed.2021.681469
Domnich, De Pace, Pennati, Caligiuri, Varesano et al., Evaluation of extraction-free RT-qPCR methods for SARS-CoV-2 diagnostics, Arch. Virol,
doi:10.1007/s00705-021-05165-0
Esteve, Catherine, Chavanet, Blot, Piroth, How should a positive PCR test result for COVID-19 in an asymptomatic individual be interpreted and managed?, Med. Mal. Infect,
doi:10.1016/j.medmal.2020.09.014
Farrell, Klatt-Cromwell, Schneider, Benefits and safety of nasal saline irrigations in a pandemic-washing COVID-19 away, JAMA Otolaryngol. Head Neck Surg,
doi:10.1001/jamaoto.2020.1622
Giarratana, Rajan, Kamala, Mendenhall, Reiner, A sprayable Acid-Oxidizing solution containing hypochlorous acid (AOS2020) efficiently and safely inactivates SARS-Cov-2: A new potential solution for upper respiratory tract hygiene, Eur. Arch. Otorhinolaryngol,
doi:10.1007/s00405-021-06644-5
Guenezan, Garcia, Strasters, Jousselin, Lévêque et al., Povidone iodine mouthwash, gargle, and nasal spray to reduce nasopharyngeal viral load in patients with COVID-19: A randomized clinical trial, JAMA Otolaryngol. Head Neck Surg,
doi:10.1001/jamaoto.2020.5490
Hatanaka, Yasugi, Sato, Mukamoto, Yamasaki, Hypochlorous acid solution is a potent antiviral agent against SARS-CoV-2, J. Appl. Microbiol,
doi:10.1111/jam.15284
Higgins, Wu, Ting, SARS-CoV-2 nasopharyngeal swab testing-false-negative results from a pervasive anatomical misconception, JAMA Otolaryngol. Head Neck Surg,
doi:10.1001/jamaoto.2020.2946
Hou, Okuda, Edwards, Martinez, Asakura et al., SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract, Cell,
doi:10.1016/j.cell.2020.05.042
Inc, Allplex 2019-nCoV Assay
Jefferson, Spencer, Brassey, Heneghan, Viral cultures for coronavirus sisease 2019 infectivity assessment: A systematic review, Clin. Infect. Dis,
doi:10.1093/cid/ciaa1764
Jiang, Liang, Effect of hypochlorous acid nasal spray as an adjuvant therapy after functional endoscopic sinus surgery, Am. J. Otolaryngol,
doi:10.1016/j.amjoto.2021.103264
Jin, Ren, Li, Gao, Zhang et al., Global burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019, EClinicalMedicine,
doi:10.1016/j.eclinm.2021.100986
Kawasuji, Takegoshi, Kaneda, Ueno, Miyajima et al., Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients, PLoS ONE,
doi:10.1371/journal.pone.0243597
Kim, Kim, Kim, Lee, Bae et al., Hypochlorous acid versus saline nasal irrigation in allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled study, Am. J. Rhinol. Allergy,
doi:10.1177/19458924211029428
Kim, Lee, Kang, Cho, Kim et al., Effects of a low concentration hypochlorous acid nasal irrigation solution on bacteria, fungi, and virus, Laryngoscope,
doi:10.1097/MLG.0b013e31817f4d34
Liao, Chen, Xiao, The generation and inactivation mechanism of oxidation-reduction potential of electrolyzed oxidizing water, J. Food Eng,
doi:10.1016/j.jfoodeng.2006.01.004
Liotti, Menchinelli, Marchetti, Morandotti, Sanguinetti et al., Evaluation of three commercial assays for SARS-CoV-2 molecular detection in upper respiratory tract samples, Eur. J. Clin. Microbiol. Infect. Dis,
doi:10.1007/s10096-020-04025-0
Luo, Morris, Sachithanandham, Amadi, Gaston et al., Infection with the SARS-CoV-2 Delta variant is associated with higher recovery of infectious virus compared to the Alpha variant in both unvaccinated and vaccinated individuals, Clin. Infect. Dis,
doi:10.1093/cid/ciab986
Marc, Kerioui, Blanquart, Bertrand, Mitjà et al., Quantifying the relationship between SARS-CoV-2 viral load and infectiousness, Elife,
doi:10.7554/eLife.69302
Saraiello, Ferrentino, Cuomo, Grimaldi, Falco et al., Correlation between cycle threshold and viral load through comparison of RT-PCR qualitative versus quantitative assay for SARS-CoV-2, Microbiol. Med,
doi:10.4081/mm.2021.9999
Schneider, Korber, Grabbe, Dissemond, Influence of pH on wound-healing: A new perspective for wound-therapy?, Arch. Dermatol. Res,
doi:10.1007/s00403-006-0713-x
Schulz, Altman, Moher, Consort Group, CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials, BMJ,
doi:10.1136/bmj.c332
Sender, Bar-On, Gleizer, Bernshtein, Flamholz et al., The total number and mass of SARS-CoV-2 virions, Proc. Natl. Acad. Sci,
doi:10.1073/pnas.2024815118
Smith, Moquin, Bernhauerova, Smith, Influenza virus infection model with density dependence supports biphasic viral decay, Front. Microbiol,
doi:10.3389/fmicb.2018.01554
Snapinn, Jiang, Iqlewicz, Informative noncompliance in endpoint trials, Curr. Control. Trials Cardiovasc. Med,
doi:10.1186/1468-6708-5-5
Stowe, Tessier, Zhao, Guy, Muller-Pebody et al., Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: A test-negative design, Int. J. Epidemiol,
doi:10.1093/ije/dyab081
Wang, Liu, Hu, Zhou, Yu et al., Nasopharyngeal swabs are more sensitive than oropharyngeal swabs for COVID-19 diagnosis and monitoring the SARS-CoV-2 load, Front. Med,
doi:10.3389/fmed.2020.00334
Winchester, John, Jabbar, John, Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection, J. Infect,
doi:10.1016/j.jinf.2021.05.009
Wölfel, Corman, Guggemos, Seilmaier, Zange et al., Virological assessment of hospitalized patients with COVID-2019, Nature,
doi:10.1038/s41586-020-2196-x
Yoon, Yoon, Song, Yoon, Lim et al., Clinical significance of a high SARS-CoV-2 viral load in the saliva, J. Korean Med. Sci,
doi:10.3346/jkms.2020.35.e195
Yu, Kim, Kang, Lim, Low-concentration hypochlorous acid nasal irrigation for chronic sinonasal symptoms: A prospective randomized placebo-controlled study, Eur. Arch. Otorhinolaryngol,
doi:10.1007/s00405-016-4387-5
Zarabanda, Vukkadala, Phillips, Qian, Mfuh et al., The effect of povidone-iodine nasal spray on nasopharyngeal SARS-CoV-2 viral load: A randomized control trial, Laryngoscope,
doi:10.1002/lary.29935
DOI record:
{
"DOI": "10.3390/v14051033",
"ISSN": [
"1999-4915"
],
"URL": "http://dx.doi.org/10.3390/v14051033",
"abstract": "<jats:p>Sentinox (STX) is an acid-oxidizing solution containing hypochlorous acid in spray whose virucidal activity against SARS-CoV-2 has been demonstrated. In this paper, results of a randomized controlled trial (RCT) on the efficacy of STX in reducing viral load in mild COVID-19 patients (NCT04909996) and a complementary in vitro study on its activity against different respiratory viruses are reported. In the RCT, 57 patients were randomized (1:1:1) to receive STX three (STX-3) or five (STX-5) times/day plus standard therapy or standard therapy only (controls). Compared with controls, the log10 load reduction in groups STX-3 and STX-5 was 1.02 (p = 0.14) and 0.18 (p = 0.80), respectively. These results were likely driven by outliers with extreme baseline viral loads. When considering subjects with baseline cycle threshold values of 20–30, STX-3 showed a significant (p = 0.016) 2.01 log10 reduction. The proportion of subjects that turned negative by the end of treatment (day 5) was significantly higher in the STX-3 group than in controls, suggesting a shorter virus clearance time. STX was safe and well-tolerated. In the in vitro study, ≥99.9% reduction in titers against common respiratory viruses was observed. STX is a safe device with large virucidal spectrum and may reduce viral loads in mild COVID-19 patients.</jats:p>",
"alternative-id": [
"v14051033"
],
"author": [
{
"ORCID": "https://orcid.org/0000-0002-2677-0551",
"affiliation": [
{
"name": "Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy"
}
],
"authenticated-orcid": false,
"family": "Panatto",
"given": "Donatella",
"sequence": "first"
},
{
"ORCID": "https://orcid.org/0000-0002-2433-9610",
"affiliation": [
{
"name": "Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy"
},
{
"name": "Hygiene Unit, San Martino Policlinico Hospital-IRCCS for Oncology and Neurosciences, 16132 Genoa, Italy"
}
],
"authenticated-orcid": false,
"family": "Orsi",
"given": "Andrea",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Hygiene Unit, San Martino Policlinico Hospital-IRCCS for Oncology and Neurosciences, 16132 Genoa, Italy"
}
],
"family": "Bruzzone",
"given": "Bianca",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Hygiene Unit, San Martino Policlinico Hospital-IRCCS for Oncology and Neurosciences, 16132 Genoa, Italy"
}
],
"family": "Ricucci",
"given": "Valentina",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "NG Scientific Consulting, 20091 Bresso, Italy"
}
],
"family": "Fedele",
"given": "Guido",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "APR Applied Pharma Research SA, via Corti 5, CH-6828 Balerna, Switzerland"
}
],
"family": "Reiner",
"given": "Giorgio",
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0000-0001-9154-6057",
"affiliation": [
{
"name": "APR Applied Pharma Research SA, via Corti 5, CH-6828 Balerna, Switzerland"
}
],
"authenticated-orcid": false,
"family": "Giarratana",
"given": "Nadia",
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0000-0001-9608-8892",
"affiliation": [
{
"name": "Hygiene Unit, San Martino Policlinico Hospital-IRCCS for Oncology and Neurosciences, 16132 Genoa, Italy"
}
],
"authenticated-orcid": false,
"family": "Domnich",
"given": "Alexander",
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0000-0002-8463-8487",
"affiliation": [
{
"name": "Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy"
},
{
"name": "Hygiene Unit, San Martino Policlinico Hospital-IRCCS for Oncology and Neurosciences, 16132 Genoa, Italy"
}
],
"authenticated-orcid": false,
"family": "Icardi",
"given": "Giancarlo",
"sequence": "additional"
},
{
"affiliation": [],
"name": "STX Study Group",
"sequence": "additional"
}
],
"container-title": "Viruses",
"container-title-short": "Viruses",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2022,
5,
15
]
],
"date-time": "2022-05-15T13:48:22Z",
"timestamp": 1652622502000
},
"deposited": {
"date-parts": [
[
2024,
7,
29
]
],
"date-time": "2024-07-29T15:09:41Z",
"timestamp": 1722265781000
},
"funder": [
{
"name": "APR, a subsidiary of RELIEF THERAPEUTICS Holding SA, Switzerland"
}
],
"indexed": {
"date-parts": [
[
2025,
2,
21
]
],
"date-time": "2025-02-21T16:37:43Z",
"timestamp": 1740155863477,
"version": "3.37.3"
},
"is-referenced-by-count": 4,
"issue": "5",
"issued": {
"date-parts": [
[
2022,
5,
12
]
]
},
"journal-issue": {
"issue": "5",
"published-online": {
"date-parts": [
[
2022,
5
]
]
}
},
"language": "en",
"license": [
{
"URL": "https://creativecommons.org/licenses/by/4.0/",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2022,
5,
12
]
],
"date-time": "2022-05-12T00:00:00Z",
"timestamp": 1652313600000
}
}
],
"link": [
{
"URL": "https://www.mdpi.com/1999-4915/14/5/1033/pdf",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "1968",
"original-title": [],
"page": "1033",
"prefix": "10.3390",
"published": {
"date-parts": [
[
2022,
5,
12
]
]
},
"published-online": {
"date-parts": [
[
2022,
5,
12
]
]
},
"publisher": "MDPI AG",
"reference": [
{
"key": "ref_1",
"unstructured": "World Health Organization (WHO) (2022, May 09). Weekly Epidemiological Update on COVID-19—4 May 2022. Available online: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---4-may-2022."
},
{
"key": "ref_2",
"unstructured": "World Health Organization (WHO) (2022, March 14). Advice for the Public: Coronavirus Disease (COVID-19). Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public."
},
{
"key": "ref_3",
"unstructured": "World Health Organization (WHO) (2022, March 14). Tracking SARS-CoV-2 Variants. Available online: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/."
},
{
"DOI": "10.1016/S1473-3099(21)00633-2",
"doi-asserted-by": "crossref",
"key": "ref_4",
"unstructured": "The Lancet Infectious Diseases (2021). Unmet need for COVID-19 therapies in community settings. Lancet Infect. Dis., 21, 1471."
},
{
"DOI": "10.3389/fmed.2021.681469",
"article-title": "COVID-19 and influenza co-infection: A systematic review and meta-analysis",
"author": "Dadashi",
"doi-asserted-by": "crossref",
"first-page": "681469",
"journal-title": "Front. Med.",
"key": "ref_5",
"volume": "8",
"year": "2021"
},
{
"DOI": "10.1016/j.jinf.2020.05.046",
"article-title": "Co-infections in people with COVID-19: A systematic review and meta-analysis",
"author": "Lansbury",
"doi-asserted-by": "crossref",
"first-page": "266",
"journal-title": "J. Infect.",
"key": "ref_6",
"volume": "81",
"year": "2020"
},
{
"DOI": "10.1093/ije/dyab081",
"article-title": "Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: A test-negative design",
"author": "Stowe",
"doi-asserted-by": "crossref",
"first-page": "1124",
"journal-title": "Int. J. Epidemiol.",
"key": "ref_7",
"volume": "50",
"year": "2021"
},
{
"DOI": "10.1016/j.addr.2021.01.019",
"article-title": "Overcoming barriers by local drug delivery with liposomes",
"author": "Antimisiaris",
"doi-asserted-by": "crossref",
"first-page": "53",
"journal-title": "Adv. Drug. Deliv. Rev.",
"key": "ref_8",
"volume": "174",
"year": "2021"
},
{
"DOI": "10.3390/pharmaceutics13101612",
"doi-asserted-by": "crossref",
"key": "ref_9",
"unstructured": "Pilicheva, B., and Boyuklieva, R. (2021). Can the nasal cavity help tackle COVID-19?. Pharmaceutics, 13."
},
{
"DOI": "10.1001/jamaoto.2020.1622",
"article-title": "Benefits and safety of nasal saline irrigations in a pandemic-washing COVID-19 away",
"author": "Farrell",
"doi-asserted-by": "crossref",
"first-page": "787",
"journal-title": "JAMA Otolaryngol. Head Neck Surg.",
"key": "ref_10",
"volume": "146",
"year": "2020"
},
{
"DOI": "10.3389/fmed.2020.00334",
"article-title": "Nasopharyngeal swabs are more sensitive than oropharyngeal swabs for COVID-19 diagnosis and monitoring the SARS-CoV-2 load",
"author": "Wang",
"doi-asserted-by": "crossref",
"first-page": "334",
"journal-title": "Front. Med.",
"key": "ref_11",
"volume": "7",
"year": "2020"
},
{
"DOI": "10.3346/jkms.2020.35.e195",
"article-title": "Clinical significance of a high SARS-CoV-2 viral load in the saliva",
"author": "Yoon",
"doi-asserted-by": "crossref",
"first-page": "e195",
"journal-title": "J. Korean Med. Sci.",
"key": "ref_12",
"volume": "35",
"year": "2020"
},
{
"DOI": "10.1038/s41586-020-2196-x",
"article-title": "Virological assessment of hospitalized patients with COVID-2019",
"author": "Corman",
"doi-asserted-by": "crossref",
"first-page": "465",
"journal-title": "Nature",
"key": "ref_13",
"volume": "581",
"year": "2020"
},
{
"DOI": "10.1016/j.cell.2020.05.042",
"article-title": "SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract",
"author": "Hou",
"doi-asserted-by": "crossref",
"first-page": "429",
"journal-title": "Cell",
"key": "ref_14",
"volume": "182",
"year": "2020"
},
{
"DOI": "10.1371/journal.pone.0243597",
"doi-asserted-by": "crossref",
"key": "ref_15",
"unstructured": "Kawasuji, H., Takegoshi, Y., Kaneda, M., Ueno, A., Miyajima, Y., Kawago, K., Fukui, Y., Yoshida, Y., Kimura, M., and Yamada, H. (2020). Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients. PLoS ONE, 15."
},
{
"article-title": "Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them",
"author": "Burton",
"first-page": "CD013627",
"journal-title": "Cochrane Database Syst. Rev.",
"key": "ref_16",
"volume": "9",
"year": "2020"
},
{
"DOI": "10.1016/j.jinf.2021.05.009",
"article-title": "Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection",
"author": "Winchester",
"doi-asserted-by": "crossref",
"first-page": "237",
"journal-title": "J. Infect.",
"key": "ref_17",
"volume": "83",
"year": "2021"
},
{
"DOI": "10.1001/jamaoto.2020.5490",
"article-title": "Povidone iodine mouthwash, gargle, and nasal spray to reduce nasopharyngeal viral load in patients with COVID-19: A randomized clinical trial",
"author": "Guenezan",
"doi-asserted-by": "crossref",
"first-page": "400",
"journal-title": "JAMA Otolaryngol. Head Neck Surg.",
"key": "ref_18",
"volume": "147",
"year": "2021"
},
{
"DOI": "10.1002/lary.29935",
"doi-asserted-by": "crossref",
"key": "ref_19",
"unstructured": "Zarabanda, D., Vukkadala, N., Phillips, K.M., Qian, Z.J., Mfuh, K.O., Hatter, M.J., Lee, I.T., Rao, V.K., Hwang, P.H., and Domb, G. (2021). The effect of povidone-iodine nasal spray on nasopharyngeal SARS-CoV-2 viral load: A randomized control trial. Laryngoscope."
},
{
"DOI": "10.1016/j.joms.2020.06.029",
"article-title": "Hypochlorous acid: A review",
"author": "Block",
"doi-asserted-by": "crossref",
"first-page": "1461",
"journal-title": "J. Oral. Maxillofac. Surg.",
"key": "ref_20",
"volume": "78",
"year": "2020"
},
{
"DOI": "10.1097/MLG.0b013e31817f4d34",
"article-title": "Effects of a low concentration hypochlorous acid nasal irrigation solution on bacteria, fungi, and virus",
"author": "Kim",
"doi-asserted-by": "crossref",
"first-page": "1862",
"journal-title": "Laryngoscope",
"key": "ref_21",
"volume": "118",
"year": "2008"
},
{
"DOI": "10.1111/jam.15284",
"article-title": "Hypochlorous acid solution is a potent antiviral agent against SARS-CoV-2",
"author": "Hatanaka",
"doi-asserted-by": "crossref",
"first-page": "1496",
"journal-title": "J. Appl. Microbiol.",
"key": "ref_22",
"volume": "132",
"year": "2022"
},
{
"DOI": "10.1016/j.jfoodeng.2006.01.004",
"article-title": "The generation and inactivation mechanism of oxidation–reduction potential of electrolyzed oxidizing water",
"author": "Liao",
"doi-asserted-by": "crossref",
"first-page": "1326",
"journal-title": "J. Food Eng.",
"key": "ref_23",
"volume": "78",
"year": "2007"
},
{
"DOI": "10.1007/s00403-006-0713-x",
"article-title": "Influence of pH on wound-healing: A new perspective for wound-therapy?",
"author": "Schneider",
"doi-asserted-by": "crossref",
"first-page": "413",
"journal-title": "Arch. Dermatol. Res.",
"key": "ref_24",
"volume": "298",
"year": "2007"
},
{
"DOI": "10.1007/s00405-021-06644-5",
"article-title": "A sprayable Acid-Oxidizing solution containing hypochlorous acid (AOS2020) efficiently and safely inactivates SARS-Cov-2: A new potential solution for upper respiratory tract hygiene",
"author": "Giarratana",
"doi-asserted-by": "crossref",
"first-page": "3099",
"journal-title": "Eur. Arch. Otorhinolaryngol.",
"key": "ref_25",
"volume": "278",
"year": "2021"
},
{
"key": "ref_26",
"unstructured": "(2022, March 14). NCT04909996, Available online: https://clinicaltrials.gov/ct2/show/NCT04909996."
},
{
"DOI": "10.1136/bmj.c332",
"article-title": "CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials",
"author": "Schulz",
"doi-asserted-by": "crossref",
"first-page": "c322",
"journal-title": "BMJ",
"key": "ref_27",
"volume": "340",
"year": "2010"
},
{
"key": "ref_28",
"unstructured": "World Health Organization (WHO) (2022, March 14). Living Guidance for Clinical Management of COVID-19. Available online: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2."
},
{
"key": "ref_29",
"unstructured": "(2022, March 14). NEJM Procedure: Collection of Nasopharyngeal Specimens with the Swab Technique. Available online: https://www.youtube.com/watch?v=DVJNWefmHjEù."
},
{
"key": "ref_30",
"unstructured": "Seegene Inc. (2022, March 14). Allplex 2019-nCoV Assay (Version 2.2; 15 April 2021) (Cat no. RP10250X/RP10252W). Instructions for Use, Available online: https://www.fda.gov/media/137178/download."
},
{
"DOI": "10.1007/s00705-021-05165-0",
"article-title": "Evaluation of extraction-free RT-qPCR methods for SARS-CoV-2 diagnostics",
"author": "Domnich",
"doi-asserted-by": "crossref",
"first-page": "2825",
"journal-title": "Arch. Virol.",
"key": "ref_31",
"volume": "166",
"year": "2021"
},
{
"DOI": "10.1093/cid/ciaa1764",
"article-title": "Viral cultures for coronavirus sisease 2019 infectivity assessment: A systematic review",
"author": "Jefferson",
"doi-asserted-by": "crossref",
"first-page": "e3884",
"journal-title": "Clin. Infect. Dis.",
"key": "ref_32",
"volume": "73",
"year": "2021"
},
{
"DOI": "10.1097/PHM.0000000000001471",
"article-title": "Interpreting the COVID-19 test results: A guide for physiatrists",
"author": "Chang",
"doi-asserted-by": "crossref",
"first-page": "583",
"journal-title": "Am. J. Phys. Med. Rehabil.",
"key": "ref_33",
"volume": "99",
"year": "2020"
},
{
"DOI": "10.1016/j.medmal.2020.09.014",
"article-title": "How should a positive PCR test result for COVID-19 in an asymptomatic individual be interpreted and managed?",
"author": "Esteve",
"doi-asserted-by": "crossref",
"first-page": "633",
"journal-title": "Med. Mal. Infect.",
"key": "ref_34",
"volume": "50",
"year": "2020"
},
{
"key": "ref_35",
"unstructured": "Clonit, S.R.L. (2022, March 14). Quanty COVID-19v2. Available online: https://www.clonit.it/en/products/infectious-diseases/respiratory-infection/rt-25v2-quanty-covid-19v2/."
},
{
"DOI": "10.1007/s10096-020-04025-0",
"article-title": "Evaluation of three commercial assays for SARS-CoV-2 molecular detection in upper respiratory tract samples",
"author": "Liotti",
"doi-asserted-by": "crossref",
"first-page": "269",
"journal-title": "Eur. J. Clin. Microbiol. Infect. Dis.",
"key": "ref_36",
"volume": "40",
"year": "2021"
},
{
"DOI": "10.4081/mm.2021.9999",
"article-title": "Correlation between cycle threshold and viral load through comparison of RT-PCR qualitative versus quantitative assay for SARS-CoV-2",
"author": "Saraiello",
"doi-asserted-by": "crossref",
"first-page": "9999",
"journal-title": "Microbiol. Med.",
"key": "ref_37",
"volume": "36",
"year": "2021"
},
{
"DOI": "10.5501/wjv.v5.i2.85",
"article-title": "Determination of 50% endpoint titer using a simple formula",
"author": "Ramakrishnan",
"doi-asserted-by": "crossref",
"first-page": "85",
"journal-title": "World J. Virol.",
"key": "ref_38",
"volume": "5",
"year": "2016"
},
{
"DOI": "10.1016/j.eclinm.2021.100986",
"article-title": "Global burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019",
"author": "Jin",
"doi-asserted-by": "crossref",
"first-page": "100986",
"journal-title": "EClinicalMedicine",
"key": "ref_39",
"volume": "37",
"year": "2021"
},
{
"DOI": "10.1007/s00405-016-4387-5",
"article-title": "Low-concentration hypochlorous acid nasal irrigation for chronic sinonasal symptoms: A prospective randomized placebo-controlled study",
"author": "Yu",
"doi-asserted-by": "crossref",
"first-page": "1527",
"journal-title": "Eur. Arch. Otorhinolaryngol.",
"key": "ref_40",
"volume": "274",
"year": "2017"
},
{
"DOI": "10.1016/j.amjoto.2021.103264",
"article-title": "Effect of hypochlorous acid nasal spray as an adjuvant therapy after functional endoscopic sinus surgery",
"author": "Jiang",
"doi-asserted-by": "crossref",
"first-page": "103264",
"journal-title": "Am. J. Otolaryngol.",
"key": "ref_41",
"volume": "43",
"year": "2022"
},
{
"DOI": "10.1177/19458924211029428",
"article-title": "Hypochlorous acid versus saline nasal irrigation in allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled study",
"author": "Kim",
"doi-asserted-by": "crossref",
"first-page": "129",
"journal-title": "Am. J. Rhinol. Allergy.",
"key": "ref_42",
"volume": "36",
"year": "2022"
},
{
"DOI": "10.1002/lary.25605",
"article-title": "Improved outcomes after low-concentration hypochlorous acid nasal irrigation in pediatric chronic sinusitis",
"author": "Cho",
"doi-asserted-by": "crossref",
"first-page": "791",
"journal-title": "Laryngoscope",
"key": "ref_43",
"volume": "126",
"year": "2016"
},
{
"DOI": "10.1073/pnas.2024815118",
"article-title": "The total number and mass of SARS-CoV-2 virions",
"author": "Sender",
"doi-asserted-by": "crossref",
"first-page": "e2024815118",
"journal-title": "Proc. Natl. Acad. Sci. USA",
"key": "ref_44",
"volume": "118",
"year": "2021"
},
{
"DOI": "10.3389/fmicb.2018.01554",
"article-title": "Influenza virus infection model with density dependence supports biphasic viral decay",
"author": "Smith",
"doi-asserted-by": "crossref",
"first-page": "1554",
"journal-title": "Front. Microbiol.",
"key": "ref_45",
"volume": "9",
"year": "2018"
},
{
"DOI": "10.3390/v13091815",
"doi-asserted-by": "crossref",
"key": "ref_46",
"unstructured": "Contreras, C., Newby, J.M., and Hillen, T. (2021). Personalized virus load curves for acute viral infections. Viruses, 13."
},
{
"key": "ref_47",
"unstructured": "Italian National Institute of Health (2022, March 14). Prevalence and Distribution of SARS-CoV-2 Variants of Public Health Interest in Italy. Available online: https://www.epicentro.iss.it/coronavirus/pdf/sars-cov-2-monitoraggio-varianti-rapporti-periodici-10-dicembre-2021.pdf."
},
{
"DOI": "10.1101/2021.08.15.21262077",
"doi-asserted-by": "crossref",
"key": "ref_48",
"unstructured": "Luo, C.H., Morris, C.P., Sachithanandham, J., Amadi, A., Gaston, D.C., Li, M., Swanson, N.J., Schwartz, M., Klein, E.Y., and Pekosz, A. (2021). Infection with the SARS-CoV-2 Delta variant is associated with higher recovery of infectious virus compared to the Alpha variant in both unvaccinated and vaccinated individuals. Clin. Infect. Dis., ciab986."
},
{
"DOI": "10.1016/S1473-3099(20)30424-2",
"article-title": "RT-PCR for SARS-CoV-2: Quantitative versus qualitative",
"author": "Han",
"doi-asserted-by": "crossref",
"first-page": "165",
"journal-title": "Lancet Infect. Dis.",
"key": "ref_49",
"volume": "21",
"year": "2021"
},
{
"DOI": "10.7554/eLife.69302",
"article-title": "Quantifying the relationship between SARS-CoV-2 viral load and infectiousness",
"author": "Marc",
"doi-asserted-by": "crossref",
"first-page": "e69302",
"journal-title": "Elife",
"key": "ref_50",
"volume": "10",
"year": "2021"
},
{
"DOI": "10.1001/jamaoto.2020.2946",
"article-title": "SARS-CoV-2 nasopharyngeal swab testing-false-negative results from a pervasive anatomical misconception",
"author": "Higgins",
"doi-asserted-by": "crossref",
"first-page": "993",
"journal-title": "JAMA Otolaryngol. Head Neck Surg.",
"key": "ref_51",
"volume": "146",
"year": "2020"
},
{
"DOI": "10.1186/1468-6708-5-5",
"article-title": "Informative noncompliance in endpoint trials",
"author": "Snapinn",
"doi-asserted-by": "crossref",
"first-page": "5",
"journal-title": "Curr. Control. Trials Cardiovasc. Med.",
"key": "ref_52",
"volume": "5",
"year": "2004"
},
{
"DOI": "10.1016/0197-2456(90)90010-Y",
"article-title": "The effect of partial noncompliance on the power of a clinical trial",
"author": "Freedman",
"doi-asserted-by": "crossref",
"first-page": "157",
"journal-title": "Control. Clin. Trials",
"key": "ref_53",
"volume": "11",
"year": "1990"
}
],
"reference-count": 53,
"references-count": 53,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.mdpi.com/1999-4915/14/5/1033"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Efficacy of the Sentinox Spray in Reducing Viral Load in Mild COVID-19 and Its Virucidal Activity against Other Respiratory Viruses: Results of a Randomized Controlled Trial and an In Vitro Study",
"type": "journal-article",
"volume": "14"
}